Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion

Journal of Surgical Oncology

Volumn 95, Issue 3, 2007, Pages 261-266

  De Manzoni, Giovanni ^a   Pedrazzani, Corrado ^a,b   Pasini, Felice ^a   Bernini, Marco ^a   Minicozzi, Anna Maria ^a   Giacopuzzi, Simone ^a   Grandinetti, Antonio ^b   Cordiano, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Adjacent organ invasion; Chemoradiotherapy; Esophageal cancer; Squamous cell carcinoma; Surgical treatment

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LUNG CARCINOMA; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THORACIC AORTA; TRACHEA CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AORTA, THORACIC; BRONCHI; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PERICARDIUM; TAXOIDS; TRACHEA;

EID: 33847201845     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20640     Document Type: Article

References (33)

1. Crosby TD, Brewster AE, Borley A, et al.: Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004;90:70-75.
2. Kaneko K, Ito H, Konishi K, et al.: Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 2003;88:18-24.
3. Ohtsu A, Boku N, Muro K, et al.: Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-2921.
4. Matsubara T, Ueda M, Kokudo N, et al.: Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001;25:279-284.
5. Tachibana M, Dhar DK, Kinugasa S, et al.: Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus. Dysphagia 2002;17:255-261.
6. Ancona E, Ruol A, Santi S, et al.: Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91:2165-2174.
7. Alexander EP, Lipman T, Harmon J, et al.: Aggressive multi-modality therapy for stage III esophageal cancer: A phase I/II study. Ann Thorac Surg 2000;69:363-368.
8. Malaisrie SC, Untch B, Aranha GV, et al.: Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: Experience at a single institution. Arch Surg 2004;139:532-538.
9. Nygaard K, Hagen S, Hansen HS, et al.: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1109.
10. Le Prise E, Etienne PL, Meunier B, et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
11. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-393.
12. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
13. Collard JM, Otte JB, Fiasse R, et al.: Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32.
14. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
15. Law S, Kwong DL, Kwok KF, et al.: Improvement in treatment results and long-term survival of patients with esophageal cancer: Impact of chemoradiation and change in treatment strategy. Ann Surg 2003;238:339-347.
16. de Manzoni G, Pedrazzani C, Laterza E, et al.: Induction chemo-radiotherapy in squamous cell carcinoma of the thoracic esophagus: Impact of increased dosage on long-term results. Ann Thorac Surg 2005;80:1176-1183.
17. Pasini F, de Manzoni G, Pedrazzani C, et al.: High pathological response rate in esophageal cancer after neoadjuvant combined-modalitá therapy: Weekly chemotherapy with dose escalating of docetaxel and concurrent radiotherapy. A phase I study. Ann Oncol 2005;16:1133-1139.
18. Laterza E, de Manzoni G, Tedesco P, et al.: Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: Long-term results of a phase II study. Ann Surg Oncol 1999;6:777-784.
19. Sobin LH, Wittekind C, editos: International Union against cancer (UICC): TNM classification of malignant tumours. 5th edition. New York: John Wiley & Sons; 1997.
20. Wittekind C, Henson DE, Hutter RVP, editors: International Union against cancer (UICC): TNM Supplement. A commentary on uniform use. 2nd edition. New York: John Wiley & Sons; 2001.
21. Thompson AM, Rapson T, Gilbert FJ, et al.: Endoscopic palliative treatment for esophageal and gastric cancer: Techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc 2004;18:1257-1262.
22. Coia LR, Gunderson LL, Haller D, et al.: Outcomes of patients receiving radiation for carcinoma of the rectum. Results of the 1988-1989 patterns of care study. Cancer 1999;86:1952-1958.
23. Horns MY, Steyerberg EW, Eijkenboom WM, et al.: Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet 2004;364:1497-1504.
24. Herskovic A, Martz K, al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
25. Shenfine J, McNamee P, Steen N, et al.: A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005;9:1-121.
26. Fockens P, Kisman K, Merkus MP, et al.: The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 1998;186:17-23.
27. Tabira Y, Yasunaga M, Nakano KY, et al.: All pathological T4 esophageal carcinomas should be categorized as stage IV. Hepato-Gastroenterology 2002;49:694-698.
28. Fujita H, Sueyoshi S, Tanaka T, et al.: Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers. J Surg Oncol 2005;90:209-219.
29. Fujita H, Sueyoshi S, Tanaka T, et al.: Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005;29:25-30.
30. Van Raemdonck D, Van Cutsem E, Menten J, et al.: Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 1997;11:828-837.
31. Laterza E, de Manzoni G, Guglielmi A, et al.: Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999;67:1466-1469.
32. Zuccaro G Jr, Rice TW, Goldblum J, et al.: Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999;94:906-912.
33. Cerfolio RJ, Bryant AS, Ohja B, et al.: The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2005;129:1232-1241.